Funding · 17 September 2024Redcliffe Labs$42MOmnichannel diagnostics service providerredcliffelabs.com ↗
FundingHealthcare & Life Sciences
Redcliffe Labs raises $42M in Series C funding
By Abha Lohia · Editor ·
Redcliffe Labs: revenue and funding and every story →
Series C
- Redcliffe Labs is an omnichannel diagnostics service provider with 80+ labs and 2,000+ collection centres
- It raised $42M in Series C funding led by IFU, with participation from LeapFrog Investments, HealthQuad and Spark Growth Ventures
- The company plans to expand into Tier-II and Tier-III cities and pursue pan-India growth through acquisitions and partnerships
What happened
- Redcliffe Labs raised $42M in Series C funding.
- The round was led by IFU (Denmark's Investment Fund for Developing Countries) with $20M.
- Existing investor LeapFrog Investments contributed $15M.
- Other existing shareholders HealthQuad and Spark Growth Ventures provided the remaining capital.
- The company will use the funds to open more labs and collection centres and expand its home collection network.
- It aims to deepen its presence in Tier-II and Tier-III cities across India.
- Redcliffe Labs is pursuing pan-India expansion through strategic partnerships and further acquisitions.
- The company has already made acquisitions in north-western India.
Why it matters
- The Indian diagnostics sector is at an inflection point with significant growth opportunities.
- Redcliffe Labs aims to democratise access to affordable, accurate diagnostics for every Indian, especially underserved populations.
- The company's operating revenue grew 2.6x to Rs 347 crore in FY23, though losses widened to Rs 345.6 crore.
- This funding follows a $61M Series B round in May 2022 and a $10M Series A in April 2021.
The business
- Redcliffe Labs is an omnichannel diagnostics service provider offering health checkup packages, individual tests, smart reports with colour-coded insights, expert consultation, AI assistance and diet plans.
- It operates 80+ labs, 2,000+ collection centres and provides home collection services with over 1,000 phlebotomists.
- The company serves 220+ cities across India and has served over 7 million patients.
- It has launched Femcliffe, India's first she-centric diagnostic platform, and GeneCliffe for DNA, chromosome and protein testing.
- Redcliffe Labs holds NABL accreditation and follows Six Sigma practices.
The founders
Who put in money
- IFU (Denmark's Investment Fund for Developing Countries) lead — Denmark's development finance institution investing in private companies in developing countries.
- LeapFrog Investments existing — A global impact investor focused on healthcare and financial services in emerging markets.
- HealthQuad existing — A healthcare-focused venture capital fund.
- Spark Growth Ventures existing — An early-stage venture capital firm.
In numbers
Rs 347 croreOperating revenue · FY23
Rs 130 croreOperating revenue · FY22
Rs 345.6 croreLosses · FY23
Rs 67.7 croreLosses · FY22
80+Labs · 2024
2,000+Collection centres · 2024
220+Cities served · 2024
7 million+Patients served · 2024
What happens next
- Open more labs and collection centres.
- Expand home collection network.
- Deepen presence in Tier-II and Tier-III cities.
- Pursue pan-India expansion through strategic partnerships and further acquisitions.
Earlier rounds
- 2022-05 · Series B · $61M
- 2021-04 · Series A · $10M
Up against
PharmEasy-owned ThyrocareHealthians1mgDr. Lal PathLabs
Words to know
- Series C
- A later-stage funding round for companies that have already proven their business model and are scaling operations.
- Omnichannel
- Providing services through multiple channels (online and offline) seamlessly.
- NABL accreditation
- National Accreditation Board for Testing and Calibration Laboratories, a quality standard for diagnostic labs in India.
- Six Sigma
- A set of techniques for process improvement, aiming for near-perfect quality (fewer than 3.4 defects per million opportunities).
The numbers around it
Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 13 August 2023 | growth | $80 million | |
| 29 September 2022 | Series B | $100-125 million | |
| 6 May 2022 | Series B | $61M | LeapFrog Investments |
Other articles talking about it
Terms in this story
- Tier-2 startups: A growing share of Indian startups now come from tier-2 and tier-3 cities and towns, helped by cheap data, lower costs and local problems that big-city founders do not see. Raising money and hiring senior talent remain the main hurdles.
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingRedcliffe Lifetech raises $61 million Series BRedcliffe Lifetech is an omnichannel diagnostics platform offering 3,500+ pathology and genetic testsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Redcliffe Labs → · All startup news on 17 September 2024 →
Is this Redcliffe Labs? Get your “Featured on StopDown” badge →